ASX Announcement from 17th January 2024 - Phase 1 CF33-hNIS (VAXINIA) Study Update Positive Early Signals
The clinical trial is titled “A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33- hNIS), Administered Intratumourally or Intravenously as a Monotherapy or in Combination with Pembrolizumab in Adult Patients with Metastatic or Advanced Solid Tumours (MAST).” The trial commenced in May 2022 and is anticipated to run for approximately 24 months while being funded from existing budgets and resources.
24 months from May 2022 - Is this the news we have all been waiting for. Is this the golden goose?
Tomorrow is the 24th May 2024 - A great day for a PS announcement.
Why IMU is a multi multi bagger, page-23592
-
- There are more pages in this discussion • 1,546 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(2.73%) |
Mkt cap ! $387.9M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.3¢ | $411.0K | 7.670M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 151903 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 557313 | 8 |
View Market Depth
| Last trade - 12.21pm 02/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |